Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade

Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade

Bibliographic Details
Main Authors: Jeong Hun Kim, Won Suk Lee, Seung Joon Lee, Hannah Yang, Hong Jae Chon, Chan Kim, Jin Hyoung Kim, Byung cheol Ahn, Dong Sung Kim, Yoonki Heo, Eun-Jin Go, Jung Sun Yum
Format: Article
Language:English
Published: BMJ Publishing Group 2022-06-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/10/6/e004799.full

Internet

https://jitc.bmj.com/content/10/6/e004799.full

Similar Items